Skip to main content

T32 Benign Hematology Training Grant

PI:  Nigel Key, MD
Re: Post-Doctoral Training Program in Benign Hematology
The post-doctoral Hematology T32 Training Grant is now accepting applications.
This NIH-funded grant supports five trainees per year, and one or more slots are available beginning July 1, 2024.

This training program in academic non-malignant hematology at the University of North Carolina at Chapel Hill (UNC-CH) is supported by the Ruth L. Kirschstein National Research Service Award. This program, which encompasses disorders of the blood, vasculature or immune system, has been extraordinarily successful in its mission to train clinical and bench researchers in hematology. The cornerstones of training include a mentored research project, focused seminars and conferences, training in the responsible conduct of research, and didactic coursework in clinical research, laboratory methodology, grantsmanship, and the academic community.

This long standing Hematology T32 Training Grant remains committed to training both MD physician-scientists and PhD scientists for careers in academic hematology and hematology research. This program will continue to train adult and pediatric hematology fellows and PhD post-doctoral candidates in areas of traditional institutional research strengths encompassing benign hematology. Both basic bench and clinical research tracks are available, with carefully selected didactic coursework to complement the training experience.  Successful applicants may also pursue a Masters in Clinical Research degree through the Gillings School of Public Health, one of the top three rated Schools of Public Health in the United States.  We are committed to increase diversity and inclusion for a career in academic hematology and hematology research.  Our faculty mentors are committed to training both MD physician-scientists and postdoctoral PhD scientists for careers in academic hematology and hematology research. Our goal of increasing the number of applicants from groups historically underrepresented (UR) in research and to provide our trainees to continue on with successful scientific careers in research related fields.

Eligibility:  The individual to be trained must be a citizen or a noncitizen national of the United States or have been lawfully admitted for permanent residence at the time of appointment. Additional details on citizenship, training period, and aggregate duration of support are available in the NIH Grants Policy Statement.

All trainees are required to pursue research training full time, normally defined as 40 hours per week, or as specified by the sponsoring institution in accordance with its own policies. Appointments are in 12-month increments.

Postdoctoral trainees must have received a PhD, MD, DDS, or comparable doctoral degree from an accredited domestic or foreign institution. Comparable doctoral degrees include, but are not limited to, the following:  DMD, DC, DO, DVM, OD, DPM, ScD, EngD, DrPH, DNSc, DPT, PharmD, ND (Doctor of Naturopathy), DSW, PsyD, as well as a doctoral degree in nursing research. Documentation by an authorized official of the degree-granting institution certifying all degree requirements have been met prior to the beginning date of the training appointment is acceptable. Individuals in postgraduate clinical training, who wish to interrupt their studies for a year or more to engage in full-time research training before completing their formal training programs, are also eligible.

Awards:  Are normally for two years, occasionally extended to three years. Covers stipend of tuition and fees for approved coursework related to training. Travel to attend scientific meetings and workshops that the institution determines to be necessary for the individual’s research training experience is an allowable expense.

Number of new positions:  Three trainee’s will be selected this year.  Additional positions may open up depending upon the success of fellowship applications by current trainees.

Application deadline:  April 1, 2024.

Award notification/activation: Trainees will be selected by June 1st and appointed to the program beginning July 1, 2024.

Acceptable areas of study for post-docs are as follows:

  • Coagulation/platelet biology
  • Hemoglobinopathies and other red cell disorders
  • Clinical research in thrombosis, hemostasis, hereditary hemorrhagic telangiectasia, or transfusion medicine.

Apply: Submit the following information to in order to be considered.

  • CV
  • 1 page personal statement (to include brief description of project and career goal).
  • 2 letters of recommendation, to include 1 from the trainee mentor.